about
Monoclonal antibodies to human transglutaminase 4The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune UveitisDifferential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.Purification and characterization of a cytosolic Ca(2+)-independent phospholipase A(2) from bovine brain.Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of BaxEpithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's diseaseDoxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell deathTransglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitisIntimal hyperplasia in loop-injured carotid arteries is attenuated in transglutaminase 2-null mice.Endoplasmic reticulum stress activates transglutaminase 2 leading to protein aggregation.Dexamethasone downregulates caveolin-1 causing muscle atrophy via inhibited insulin signaling.Cysteamine prevents the development of lens opacity in a rat model of selenite-induced cataract.Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress.TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation.Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway.Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production.Cystamine induces AIF-mediated apoptosis through glutathione depletion.Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function.Sirt1 Regulates DNA Methylation and Differentiation Potential of Embryonic Stem Cells by Antagonizing Dnmt3l.Lack of transglutaminase 2 diminished T-cell responses in mice.4-n-butylresorcinol enhances proteolytic degradation of tyrosinase in B16F10 melanoma cells.S-nitrosylation of transglutaminase 2 impairs fatty acid-stimulated contraction in hypertensive cardiomyocytes.Structure of natural variant transglutaminase 2 reveals molecular basis of gaining stability and higher activityRegulation of Transglutaminase 2 by Oxidative StressTransglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell–T cell interactionTransglutaminase 2 modulates antigen-specific antibody response by suppressing Blimp-1 and AID expression of B cells in miceMonitoring Glutathione Dynamics and Heterogeneity in Living Stem CellsCompetitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2Keratinocyte transglutaminase 2 promotes CCR6+ γδT-cell recruitment by upregulating CCL20 in psoriatic inflammationGlutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway
P50
Q24328762-60316A15-A12C-4D67-A36E-EFD5CA9D2D73Q28551977-90B89763-6241-4CD9-8C29-4495DA8A1D29Q33809160-F817F5C6-25C9-4393-8962-AF107B8BFDA3Q34004751-C03D174D-67C4-48A7-BE92-087ED7C1C2E7Q34142460-25C22E10-395D-49C8-B5AE-DD527C399F3EQ34161250-EBFB51DA-77DF-41A5-8447-0413D62B6470Q35144563-6AB02024-9C80-4675-8D4B-DCDAF0AC8BF2Q36276521-2C4E0571-FC94-48A2-B767-EB1A2B5F3AC2Q37461477-18EA1D34-EBD7-4EEE-9BBF-838271C08297Q37463907-170514AD-0D8D-464F-9523-D65051925D9BQ37622205-8D6B10D6-6AB5-4658-910C-8571544FEA6CQ37685405-D36EE3A4-7F7E-4CDB-9E84-2874DED9ACA8Q38908854-7F4A9F84-1C57-4803-85BF-F77BA4BC3158Q39405491-7D79B6AA-E6DE-44E4-98B6-43D2481ABBC6Q39888950-2FA3ADD2-61F4-429D-A97D-C4BB1EF8267AQ40000510-7B22E855-B7CC-4E99-A9A1-6E689B1E23E6Q41634435-D67A6C6F-1F8B-45F3-8E76-9F6CAC37C1D8Q44635141-B226A8DE-6A00-4241-BA62-B5F59EAC9BF4Q46791739-EA64FCB3-EE50-4C52-9642-7024DA70330CQ47226486-147A222B-DAE8-4104-80E7-463043ACF81EQ50454414-6F6B4F45-8020-4E84-870F-C76C9E787903Q50857431-1A84446D-76FF-4346-AC6E-32C9E289A074Q51463902-0F7AF219-B6A8-45F3-B4AE-950009570332Q52603787-E8AADC4B-DDC7-493E-A25E-41AAE858AB2BQ57465669-CDCBD981-B92F-41EC-8D58-755A4488AB89Q62590503-00EF52B5-7894-4389-9903-9C0FC429D093Q62590504-C4614386-A504-4688-8217-051428A065C4Q62590505-5B924BA6-EE3E-44D2-B53B-D0A5594EE711Q92145771-18388CF1-1EC0-4325-997F-3076CC099B3DQ93006482-37777342-BF08-45B7-95B9-718C9916DC0CQ94474109-87E436D6-3D91-4D11-85C3-E796ABA1E9A7Q96110534-EA0D5449-C7CA-47A9-9BF0-CEB9274430F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eui Man Jeong
@ast
Eui Man Jeong
@en
Eui Man Jeong
@es
Eui Man Jeong
@nl
Eui Man Jeong
@sl
type
label
Eui Man Jeong
@ast
Eui Man Jeong
@en
Eui Man Jeong
@es
Eui Man Jeong
@nl
Eui Man Jeong
@sl
prefLabel
Eui Man Jeong
@ast
Eui Man Jeong
@en
Eui Man Jeong
@es
Eui Man Jeong
@nl
Eui Man Jeong
@sl
P106
P1153
24512295400
P31
P496
0000-0003-0692-2033